> ## Content Index > Fetch the complete content index at: https://newsletters.qs.com/llms.txt > Use this file to discover other available public pages before exploring further. # πŸ’Š Health Futures #39 - URL: https://newsletters.qs.com/health-futures-39/ - Published: 2024-10-14T11:30:14.000Z - Updated: 2024-10-14T11:30:13.000Z - Description: HolonIQ's Health Newsletter covers the latest developments in targeted chronic disease management, AI in health, and biotechnology and highlights the week's top health deals. - Author: QS - Tags: Health Skills **Happy Monday πŸ‘‹** This week, Novo Nordisk’s obesity drug, Wegovy, is to be[ released](https://www.pharmaceutical-technology.com/news/telix-health-canada-illuccix-label-expansion/?cf-view&ref=newsletters.qs.com) in Korea this month which potentially increases the competition in the obesity drug market. Royal Philips, Siloam Hospitals Group, and Universitas Pelita Harapan [signed ](https://www.miragenews.com/siloam-philips-forge-ai-pact-for-indonesias-1331608/?ref=newsletters.qs.com#google%5Fvignette)a Memorandum of Understanding to advance AI capabilities and development in the healthcare sector in Indonesia. Meanwhile, ABL Bio Corp has [entered](https://www.thepharmaletter.com/abl-bio-inks-clinical-collaboration-with-merck?ref=newsletters.qs.com) into a clinical trial collaboration and supply agreement with MSD to evaluate ABL103 in combination with Keytruda, potentially using ABL103 as a treatment for various cancers in the biotechnology sector. In health finance, Maven Clinic secured [$125M](https://www.finsmes.com/2024/10/maven-clinic-raises-125m-in-series-f-funding.html?ref=newsletters.qs.com#google%5Fvignette) in Series F funding, for which the company intends to expand its partnerships in maternity care. ## 🎯 Targeted Chronic Disease Management πŸŽ—οΈ **Telix Pharmaceuticals secured the expansion of the** [**approval**](https://www.pharmaceutical-technology.com/news/telix-health-canada-illuccix-label-expansion/?cf-view&ref=newsletters.qs.com) **of Health Canada for Illuccix.** Illuccix can now be used to identify progressive metastatic castration-resistant prostate cancer (mCRPC) patients eligible for Pluvicto treatment. **πŸ’Š The NHS** [**proposed** ](https://www.thepharmaletter.com/nhs-england-plans-phased-obesity-drug-launch?ref=newsletters.qs.com)**a phased launch of Mounjaro/Zepbound for obesity treatment.** The NHS plans to prioritize patients most likely to benefit from weight loss when providing access to Mounjaro/Zepbound. 🩺 **Novo Nordisk's obesity drug, Wegovy, will be**[ **released**](https://www.mk.co.kr/en/it/11132519?ref=newsletters.qs.com) **in Korea.** The launch of Wegovy is expected to increase competition in the domestic obesity drug market. ## 🌐 AI in Health πŸ€– **Royal Philips, Siloam Hospitals Group, and Universitas Pelita Harapan have** [**signed**](https://www.miragenews.com/siloam-philips-forge-ai-pact-for-indonesias-1331608/?ref=newsletters.qs.com#google%5Fvignette) **a Memorandum of Understanding.** The MOU aims to advance AI capabilities and development in the healthcare sector in Indonesia. **πŸ›’ Kipu Health** [**partners**](https://www.prnewswire.com/news-releases/kipu-health-collaborates-with-aws-to-bring-cutting-edge-generative-ai-to-behavioral-health-industry-302268383.html?ref=newsletters.qs.com) **with Amazon Web Services.** The collaboration will focus on developing AI solutions that streamline clinical workflows and reduce the administrative burden on healthcare providers. πŸ“Ή **Verbal**[ **launched**](https://www.prnewswire.com/news-releases/verbal-launches-ai-powered-qa-training-and-documentation-tools-for-zoom-virtual-care-visits-302268059.html?ref=newsletters.qs.com) **its AI tools in the Zoom app marketplace.** This integration allows telehealth providers to automatically capture and analyze call audio and use Verbal's AI-powered clinical documentation and real-time quality assurance tools. ## 🧬 Biotechnology πŸ”¬ **Mestag Therapeutics** [**entered**](https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/latest-pharmaceutical-manufacturing-news/mestag-msd-to-identify-novel-targets-for-inflammatory-diseases/?ref=newsletters.qs.com) **into a license and collaboration agreement with MSD.** The agreement aimsto identify novel targets for the development of therapies against inflammatory diseases. πŸ§ͺ **MediLink Therapeutics entered into a clinical trial** [**collaboration**](https://www.prnewswire.com/news-releases/medilink-announces-global-clinical-trial-collaboration-and-supply-agreement-on-yl201-combination-therapy-302268140.html?ref=newsletters.qs.com) **and supply agreement with Amgen.** This collaboration aims to explore the potential of the two innovative drugs in the treatment of ES-SCLC and offer a novel and synergetic mechanism of action for clinical benefit. 🧫 **ABL Bio Corp**[ **entered** ](https://www.thepharmaletter.com/abl-bio-inks-clinical-collaboration-with-merck?ref=newsletters.qs.com)**into a clinical trial collaboration and supply agreement with MSD.** ABL Bio will conduct a phase Ib/II clinical trial to evaluate the safety and efficacy of ABL103 in combination with Keytruda. ## **πŸ’°** Deals of the Week πŸ₯ **Maven Clinic** secured [$125M](https://www.finsmes.com/2024/10/maven-clinic-raises-125m-in-series-f-funding.html?ref=newsletters.qs.com) in Series F funding which the company intends to use the funds to enhance its partnerships in maternity care. πŸ’΅ **The Transform Health Fund** has raised [$111M](https://www.practical-patient-care.com/news/transform-health-fund-raises-111m-for-healthcare-access-in-africa/?cf-view&ref=newsletters.qs.com) to bolster healthcare systems in Africa. The fund is supported by the Health Finance Coalition. βš–οΈ **Eleanor Health** raised [$30M](https://www.finsmes.com/2024/10/eleanor-health-raises-30m-in-series-d-funding.html?ref=newsletters.qs.com) in Series D funding. Eleanor Health aims to use the funds to continue scaling its whole-person care model for substance use disorder. πŸ“‹ **MARAbio** raised [$19M](https://www.finsmes.com/2024/10/marabio-raises-19m-in-initial-series-a-funding.html?ref=newsletters.qs.com) in initial Series A funding, intending to use the funds to support the commercial launch of its autism test in the coming year and the development of therapeutic interventions. πŸ‘οΈ **InterVene** raised [$13M](https://www.finsmes.com/2024/10/intervene-raises-13m-in-series-a-financing.html?ref=newsletters.qs.com) in Series A funding, which the funds secured will used to further enhance the final development of its Recana catheter system, initiation of clinical cases, regulatory submission, and market clearance in the US. --- **Thank you for reading. Have a great week ahead!** Have some feedback or suggestions? Let us know at hello@holoniq.com [ ](https://newsletters.qs.com/psychedelic-mental-health-treatments-south-asia-health-tech-100-2/)